This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Orchid Chemicals & Pharmaceuticals Limited. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Arvind Atmaram Jangale: Innovator in Antibiotic Development
Introduction
Arvind Atmaram Jangale is a notable inventor based in Aurangabad, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibiotics. His innovative work has led to the creation of a patented process that enhances the preparation of a crucial antibiotic.
Latest Patents
Jangale holds a patent for the "Process for the preparation of beta-lactam antibiotic meropenem trihydrate." This process involves the dissolution of Meropenem in water in the presence of a base, adjusting the pH to a range of 4.0-7.0, and subsequently adding a solvent to yield purified Meropenem trihydrate. This innovation is vital for improving the efficacy and purity of this important antibiotic.
Career Highlights
Arvind Jangale is associated with Orchid Chemicals & Pharmaceuticals Limited, a prominent player in the pharmaceutical industry. His work at the company has been instrumental in advancing antibiotic production techniques. His dedication to research and development has positioned him as a key figure in the field.
Collaborations
Jangale has collaborated with talented coworkers, including Senthilkumar Surulichamy and Selvakumar Sekar. Their combined expertise has contributed to the successful development of innovative pharmaceutical processes.
Conclusion
Arvind Atmaram Jangale's contributions to antibiotic development through his patented process exemplify the importance of innovation in the pharmaceutical industry. His work not only enhances the production of essential medications but also showcases the potential of collaboration in achieving significant advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
